Please login or sign up to post and edit reviews.
The FDA’s Pressure-Packed Alzheimer’s Drug Decision
Podcast |
Tradeoffs
Publisher |
Tradeoffs
Media Type |
audio
Categories Via RSS |
News
News & Politics
Science
Publication Date |
Jun 03, 2021
Episode Duration |
00:21:51

The U.S. Food and Drug Administration faces a costly and consequential decision over whether to approve a controversial new Alzheimer’s drug.

Guest:

Caleb Alexander, Professor of Epidemiology and Medicine, Johns Hopkins Bloomberg School of Public Health

View the transcript for today's episode: https://tradeoffs.org/2021/06/03/the-fdas-pressure-packed-alzheimers-drug-decision

Take our short listener survey, and you could win a $50 gift card! bit.ly/TradeoffsSurvey

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletter

Support this type of journalism today, with a gift: https://tradeoffs.org/donate

Follow us on Twitter: https://twitter.com/tradeoffspod


Hosted on Acast. See acast.com/privacy for more information.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review